Argentum and MatrixCare are recognizing seven innovations they say improve resident care and quality of life for assisted living residents with dementia.
More news for Thursday, Feb. 27
Feb 27, 2020
Task force issues final recommendation on dementia screening … LeadingAge gathers coronavirus preparedness resources … ABC plans ‘Bachelor’ for seniors
Bill Gates sets aside $100 million for Alzheimer’s research
By
John O'Connor
Nov 14, 2017
Billionaire Bill Gates announced he will invest $50 million in the Dementia Discovery Fund. The venture capital fund links targets the disease by coordinating public and private-sector efforts.
More news for Monday, Nov. 28
Nov 27, 2016
Why Eli Lilly’s failed dementia drug could chill Alzheimer’s research spending … Memory care community separates men and women
More news for Tuesday, June 26
Jun 26, 2018
AARP invests $60 million in dementia and Alzheimer’s research … Defendant sentenced in multimillion dollar telemarketing scam targeting elderly victims
Staff training could reduce resident aggression in assisted living: study
By
Lois A. Bowers
Aug 10, 2016
Assisted living communities could help reduce incidents stemming from aggressive and abusive behaviors in residents by training staff members to detect and manage the early signs of problematic behaviors...
Dementia drug helps prevent falls in those with Parkinson’s
By
Lois A. Bowers
Jan 13, 2016
A drug commonly prescribed to treat symptoms of dementia could help prevent falls for people with Parkinson’s disease, according to new research.
Coalition cites ‘urgent need’ in releasing best practices for assisted living
By
Lois A. Bowers
Oct 25, 2018
The Long Term Care Community Coalition released recommendations for best practices for the assisted living industry on Wednesday, citing an “urgent need” given the findings contained in a February...
DMARDs not linked to Alzheimer’s risk for seniors with RA
Apr 12, 2022
No reduction in the risk for Alzheimer’s disease and related dementia was seen with treatment with tofacitinib, tocilizumab or tumor necrosis factor inhibitors versus abatacept.
Frontline staff effective in reducing antipsychotic use: study
By
Lois A. Bowers
Apr 17, 2017
The off-label use of antipsychotic medication to treat cognitively impaired residents can be significantly reduced by training frontline staff members to recognize that individuals may exhibit challenging...